The National Institutes of Health (NIH) is offering this grant to support the rigorous evaluation of early-stage diagnostics and novel strategies for Tuberculosis (TB) in countries where the disease is prevalent. This grant is for the purpose of advancing the understanding and implementation of new diagnostic technologies within existing clinical frameworks. Successful projects will conduct crucial proof-of-principle studies on innovative TB tests and strategies, including those applicable to people living with HIV (PLWH). A key aim is to generate essential feedback for diagnostic developers and policymakers regarding the real-world performance of these technologies and to identify the most effective deployment strategies for their use in endemic settings. The initiative seeks to bridge the gap between diagnostic innovation and practical application, improving TB detection globally.
Opportunity ID: 353243
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-24-010 |
| Funding Opportunity Title: | Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 27, 2024 |
| Last Updated Date: | Mar 27, 2024 |
| Original Closing Date for Applications: | Jun 28, 2024 |
| Current Closing Date for Applications: | Jun 28, 2024 |
| Archive Date: | Aug 03, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $3,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments City or township governments Special district governments Public housing authorities/Indian housing authorities County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this notice of funding opportunity (NOFO) is to support the evaluation of early-stage diagnostics and novel diagnostic strategies for Tuberculosis (TB) in the context of existing clinical algorithms in TB endemic countries. Evaluation studies should: 1) perform proof-of principle studies of novel diagnostic tests and strategies for TB, including among people living with HIV (PLWH) and 2) provide feedback to diagnostic developers and policy makers on the performance of the technologies and most effective strategies for use of the diagnostic technologies in an endemic setting. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-010.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 353243 Full Announcement-RFA-AI-24-010 -> RFA-AI-24-010-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00285617 | May 28, 2024 | Jun 28, 2024 | View |
Package 1
Mandatory forms
353243 RR_SF424_5_0-5.0.pdf
353243 PHS398_CoverPageSupplement_5_0-5.0.pdf
353243 RR_OtherProjectInfo_1_4-1.4.pdf
353243 PerformanceSite_4_0-4.0.pdf
353243 RR_KeyPersonExpanded_4_0-4.0.pdf
353243 PHS398_ResearchPlan_5_0-5.0.pdf
353243 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353243 RR_Budget_3_0-3.0.pdf
353243 RR_SubawardBudget30_3_0-3.0.pdf
353243 PHS398_ModularBudget_1_2-1.2.pdf
353243 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
